SCHEMBL4675290

SCHEMBL4675290

CN(C)S(=O)(=O)N1CCN(S(=O)(=O)N2CCC(C(=O)c3ccc(Cl)cc3)CC2)[C@@H](C(=O)NO)C1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
TP53 P04637 1/20 0.51
MAPT P10636 1/20 0.51
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
FPR2 P25090 1/20 0.43
PROKR1 Q8TCW9 1/20 0.43
MGLL Q99685 5/20 0.41
MMP1 P03956 2/20 0.40
MMP3 P08254 2/20 0.40
MMP7 P09237 2/20 0.40
MMP9 P14780 2/20 0.40
MMP13 P45452 2/20 0.40
CYP3A4 P08684 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7500686 0.88 LMNA (0.53) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL4672936 0.86 LMNA (0.51) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL7508099 0.86 LMNA (0.51) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL4671319 0.85 LMNA (0.54) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL4673603 0.83 LMNA (0.51) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL7577834 0.83 LMNA (0.51) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL4670698 0.82 LMNA (0.50) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL4673704 0.82 LMNA (0.50) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL6267900 0.81 LMNA (0.56) LMNAL3MBTL1TP53MAPTMEN1
SCHEMBL4670789 0.81 LMNA (0.56) LMNAL3MBTL1TP53MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 US disclosed